Fundraising FoxGLO Pharma
Encinitas, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into GLO Pharma
Sign up to see every warm intro you have to GLO Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GLO Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
JM
Jana MessersmithBoard director
LO
Lauren OtsukiBoard director
TJ
Todd JacksonBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$60.4M disclosed across 3 rounds · 2020–2021
▶$53MraisedSep 2023 · 189 investors · BiotechnologyRule 506(b)
▶$53MraisedSep 2023 · 189 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dayna QuanbeckDirector
- Nicole QuinnDirector
- Marla BeckDirector
- Maureen CaseDirector
- Fabian SeelbachDirector
- Douglas WallDirector
- Lauren OtsukiDirector, Executive Officer
- Vimla Black-GuptaExecutive Officer, Director
- Offering amount
- $53M
- Amount sold
- $53M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$6.8MraisedNov 2020 · 20 investors · PharmaceuticalsRule 506(b)
▶$6.8MraisedNov 2020 · 20 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jana MessersmithDirector
- Lauren OtsukiDirector
- Scott GlennExecutive Officer, Director
- Todd JacksonDirector
- Offering amount
- $6.8M
- Amount sold
- $6.8M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$511KraisedNov 2020 · 22 investors · PharmaceuticalsRule 506(b)
▶$511KraisedNov 2020 · 22 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Scott GlennExecutive Officer, Director
- Jana MessersmithDirector
- Todd JacksonDirector
- Lauren OtsukiDirector
- Offering amount
- $511K
- Amount sold
- $511K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are GLO Pharma's investors?
- GLO Pharma's investors include Lightspeed Venture Partners.
- How much funding has GLO Pharma raised?
- GLO Pharma has disclosed $60.4M raised across 3 rounds.
- Where is GLO Pharma headquartered?
- GLO Pharma is headquartered in Encinitas, US.